can glp-1 be used in type 1 diabetes medications beneficial for people with diabetes? While not FDA-approved for T1D, their off-label use is increasing — especially among those with insulin resistance or a higher BMI People ask if GLP-1s work

The Danish firm wanted to refine the approach, and its research finally bore fruit

Within this evolving landscape, SureNano Science is positioning itself as an agile entrant pursuing differentiated innovation through GEP-44, a patented triple agonist peptide licensed from Syracuse University and designed to advance through the U.S

this evidence suggests the ease of practical clinical application

Clinical observations from practitioners using microdosed GLP-1 in Hashimoto patients report improvements in thyroid antibody levels (TPO and thyroglobulin antibodies) and reductions in thyroid-related fatigue

Monitoring and Safety Guidance for GLP-1 Users in the UK For patients appropriately prescribed GLP-1 receptor agonists, routine thyroid cancer screening is not recommended according to the product information for these medications